CorDynamics is the only CRO providing clients with tailored study designs, collaborative model development and industry know-how to aid in all stages of drug discovery.

Our drug discovery services offer a streamlined process with an eye on industry compliance and customizable design to replicate nearly any experimental scenario. Our experienced researchers understand the need for quick turnaround time, solid data and expert interpretation to address the pressing cardiovascular questions surrounding lead optimization.

DRUG DISCOVERY

  • Heart Failure – with reduced (HFrEF) and preserved (HFpEF) ejection fraction
  • Pulmonary Arterial Hypertension
  • Atrial Fibrillation
  • Thrombosis
  • Ischemia/Reperfusion

Looking for more information on our drug development research? Delve into our publications or contact us directly to start a discussion.